Drug Shortage Report for AURO-ALENDRONATE

Last updated on 2018-07-12 History
Report ID 47445
Drug Identification Number 02388545
Brand name AURO-ALENDRONATE
Common or Proper name Alendronate
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) ALENDRONIC ACID
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2018-03-30
Actual start date
Estimated end date 2018-05-18
Actual end date 2018-05-31
Shortage status Resolved
Updated date 2018-07-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Anahita Rostami

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-07-12 English Compare
v3 2018-04-30 French Compare
v2 2018-04-30 English Compare
v1 2018-04-30 English Compare

Showing 1 to 4 of 4